Loading…
UTI - Pharma & Healthcare Fund
Disclosed for 41 months, Jan 2014 to Jun 2017. This scheme is no longer reporting.
Portfolio value
₹325 Cr
up ₹2.8 Cr vs Feb 2017
- Stocks held
- 29
- up 2 vs Feb 2017
- Top 10 weight
- 62.6%
- of the portfolio in its ten largest
- Cash & debt
- 4.3%
- cash, money market and debt
- Moves this month
- 3 in · 1 out
- added to 10, trimmed 8
UTI - Pharma & Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In March 2017 it disclosed 29 stocks worth ₹325 Cr, up ₹2.8 Cr from Feb 2017. Its largest positions were Sun Pharmaceutical Industries Limited (17.3%), Cipla Limited (8.8%), Aurobindo Pharma Limited (7.6%); the ten largest together made up 62.6% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 77.7% of its equity. Cash and debt stood at 4.3%. Compared with Feb 2017 the fund entered 3 new stocks and exited 1.
Against 227 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
64%
Holds more cash than 64% of peers
Holdings in March 2017
Download CSVEvery line the fund disclosed, with the change against Feb 2017. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 17.26%
- Δ weight
- down 3.92 pts
- Value
- ₹56.1 Cr
- Δ value
- down ₹12.2 Cr
- Status
- Trimmed
- Weight
- 8.79%
- Δ weight
- down 1.02 pts
- Value
- ₹28.6 Cr
- Δ value
- down ₹3.1 Cr
- Status
- Trimmed
- Weight
- 7.64%
- Δ weight
- up 2.01 pts
- Value
- ₹24.9 Cr
- Δ value
- up ₹6.7 Cr
- Status
- Added
- Weight
- 7.05%
- Δ weight
- down 3.33 pts
- Value
- ₹22.9 Cr
- Δ value
- down ₹10.5 Cr
- Status
- Trimmed
- Weight
- 4.99%
- Δ weight
- up 0.10 pts
- Value
- ₹16.2 Cr
- Δ value
- up ₹47 L
- Status
- Added
- Weight
- 4.34%
- Δ weight
- up 0.10 pts
- Value
- ₹14.1 Cr
- Δ value
- up ₹43 L
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 4.28%
- Δ weight
- up 2.63 pts
- Value
- ₹13.9 Cr
- Δ value
- up ₹8.6 Cr
- Status
- Added
- Weight
- 3.56%
- Δ weight
- up 2.59 pts
- Value
- ₹11.6 Cr
- Δ value
- up ₹8.5 Cr
- Status
- Added
- Weight
- 3.02%
- Δ weight
- up 0.82 pts
- Value
- ₹9.8 Cr
- Δ value
- up ₹2.7 Cr
- Status
- Added
- Weight
- 3.00%
- Δ weight
- up <0.01 pts
- Value
- ₹9.8 Cr
- Δ value
- up ₹9 L
- Status
- Added
- Weight
- 2.93%
- Δ weight
- up 0.01 pts
- Value
- ₹9.5 Cr
- Δ value
- up ₹12 L
- Status
- Added
- Weight
- 2.92%
- Δ weight
- down 0.01 pts
- Value
- ₹9.5 Cr
- Δ value
- up ₹4 L
- Status
- Held
- Weight
- 2.81%
- Δ weight
- up 0.29 pts
- Value
- ₹9.1 Cr
- Δ value
- up ₹1 Cr
- Status
- Added
- Weight
- 2.49%
- Δ weight
- down 0.56 pts
- Value
- ₹8.1 Cr
- Δ value
- down ₹1.8 Cr
- Status
- Trimmed
- Weight
- 2.43%
- Δ weight
- down 0.11 pts
- Value
- ₹7.9 Cr
- Δ value
- down ₹28 L
- Status
- Trimmed
- Weight
- 2.37%
- Δ weight
- down 0.17 pts
- Value
- ₹7.7 Cr
- Δ value
- down ₹48 L
- Status
- Trimmed
- Weight
- 2.30%
- Δ weight
- up 0.71 pts
- Value
- ₹7.5 Cr
- Δ value
- up ₹2.4 Cr
- Status
- Added
- Weight
- 2.07%
- Δ weight
- up 2.07 pts
- Value
- ₹6.7 Cr
- Δ value
- up ₹6.7 Cr
- Status
- New
- Weight
- 2.07%
- Δ weight
- down 6.36 pts
- Value
- ₹6.7 Cr
- Δ value
- down ₹20.5 Cr
- Status
- Trimmed
- Weight
- 2.05%
- Δ weight
- up 2.05 pts
- Value
- ₹6.7 Cr
- Δ value
- up ₹6.7 Cr
- Status
- New
- Weight
- 2.04%
- Δ weight
- up 0.05 pts
- Value
- ₹6.6 Cr
- Δ value
- up ₹22 L
- Status
- Added
- Weight
- 1.96%
- Δ weight
- up 1.10 pts
- Value
- ₹6.4 Cr
- Δ value
- up ₹3.6 Cr
- Status
- Added
- Weight
- 1.59%
- Δ weight
- up 0.07 pts
- Value
- ₹5.2 Cr
- Δ value
- up ₹27 L
- Status
- Added
- Weight
- 1.54%
- Δ weight
- up 0.19 pts
- Value
- ₹5 Cr
- Δ value
- up ₹67 L
- Status
- Added
- Weight
- 1.22%
- Δ weight
- up 0.85 pts
- Value
- ₹4 Cr
- Δ value
- up ₹2.8 Cr
- Status
- Added
- Weight
- 1.08%
- Δ weight
- up 0.01 pts
- Value
- ₹3.5 Cr
- Δ value
- up ₹8 L
- Status
- Added
- Weight
- 0.68%
- Δ weight
- up 0.08 pts
- Value
- ₹2.2 Cr
- Δ value
- up ₹27 L
- Status
- Added
- Weight
- 0.66%
- Δ weight
- down 0.41 pts
- Value
- ₹2.1 Cr
- Δ value
- down ₹1.3 Cr
- Status
- Trimmed
- Weight
- 0.58%
- Δ weight
- down 0.01 pts
- Value
- ₹1.9 Cr
- Δ value
- down ₹1 L
- Status
- Held
- Weight
- 0.31%
- Δ weight
- up 0.31 pts
- Value
- ₹1 Cr
- Δ value
- up ₹1 Cr
- Status
- New
What changed, Feb 2017 to Mar 2017
New New positions (3)
- Max India Limited2.1% · ₹6.7 Cr
- Dr. Lal Path Labs Limited2.1% · ₹6.7 Cr
- FDC Limited0.3% · ₹1 Cr
Exited Exited (1)
- Thyrocare Technologies Limitedwas 0.2% · ₹51 L
Added Biggest additions
- Sanofi India Limitedup ₹8.5 Cr (+2.59% pts)
- Aurobindo Pharma Limitedup ₹6.7 Cr (+2.01% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Feb 2017, the weight rose most in Healthcare Services (+3.8 pts) and Pharmaceuticals (+3.2 pts), and fell most in Pharmaceuticals & Biotechnology (−7.3 pts).
- Healthcare Services5.8% → 9.7%+3.8 pts
- Pharmaceuticals4.9% → 8.1%+3.2 pts
- Finance4.3% → 4.5%+0.2 pts
- Pharmaceuticals & Biotechnology85.0% → 77.7%−7.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2014 | Mar 2016 | Sep 2016 | Dec 2016 | Feb 2017 | Mar 2017 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 90.5% | 87.1% | 85.9% | 85.1% | 85.0% | 77.7% |
| Healthcare Services | — | 5.0% | 5.5% | 6.4% | 5.8% | 9.7% |
| Pharmaceuticals | 8.4% | 4.7% | 4.5% | 4.6% | 4.9% | 8.1% |
| Finance | 1.1% | 3.2% | 4.1% | 3.9% | 4.3% | 4.5% |
Allocation in Mar 2017change vs Feb 2017
- Pharmaceuticals & Biotechnology (19)77.7%▼ 7.3 pts
- Healthcare Services (5)9.7%▲ 3.8 pts
- Pharmaceuticals (4)8.1%▲ 3.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Mar 2017
4.3%
▲ 2.6 pts vs Feb 2017
- Cash alone
- 4.3%
- cash and net receivables
- A year earlier
- 7.9%
- Mar 2016 · now ▼ 3.6 pts
- Last 12 months
- 0.7% – 7.6%
- lowest to highest · record 12.6% in Nov 2015
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.